Thermo Fisher Scientific Inc., a global leader in life sciences tools, said Wednesday that net income for its second quarter was $278.5 million as revenue increased 33 percent to $4.32 billion.
In February, Waltham-based Thermo Fisher Scientific completed its previously announced $13.6 billion acquisition of Life Technologies Corp., a deal that gives Thermo Fisher Scientific a bigger presence in the emerging field of genetic screening. Thermo Fisher also had to make some divestitures to fulfill an agreement with European regulators that enabled the Life Technologies transaction to go forward.
In a Wednesday press release on second-quarter earnings, Thermo Fisher Scientific highlighted adjusted earnings per share. They grew by 30 percent to $1.72.
Thermo Fisher Scientific said it now expects revenue for 2014 to be in the range of $16.86 billion to $16.98 billion versus its previous guidance of $16.84 to $17 billion, with year-over-year revenue growth remaining at 29 to 30 percent.
The company added that it is raising adjusted EPS guidance to a new range of $6.85 to $6.97 from the $6.80 to $6.95 previously announced.
Chris Reidy can be reached at email@example.com.